Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety, Tolerability, and Pharmacokinetics of CAL056 Mesylate in Patients With Resistant or Refractory Solid Tumors
- First Posted Date
- 2020-12-28
- Last Posted Date
- 2023-04-25
- Lead Sponsor
- Calgent Biotechnology Co., Ltd
- Target Recruit Count
- 17
- Registration Number
- NCT04686383
- Locations
- 🇺🇸
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸NEXT Oncology, 2829 Babcock Road Suite 300, San Antonio, Texas, United States
🇨🇳Tzu Chi General Hospital, Taipei Branch, New Taipei City, Taiwan
News
No news found